Background: Bronchial occlusion using an endobronchial Watanabe spigot (EWS) is reportedly effective for intractable bronchopleural fistula. Here, we describe a rapid and easy method for bronchial occlusion using a guide sheath (GS) and curette.
B ronchial occlusion using an endobronchial Watanabe spigot (EWS; Novatech, La Ciotat, France) has proven effective in the treatment of bronchopleural fistula that is refractory to chest drainage in patients who are not candidates for surgery. 1 However, plugging EWS into a target bronchus correctly is not necessarily easy, especially if the target bronchus is sharply branching, as in the upper lobe. Several techniques that make it easier to insert an EWS into the bronchus have been reported. [2] [3] [4] [5] Among these techniques, one of the most useful is the curette method. 3 However, this method requires pushing the EWS with the bronchoscope while pulling off the curette and embedding the EWS. This results in a temporary loss of the endoscopic view and may cause an EWS to fall out of the target bronchus. To solve this problem, we have devised a method for bronchial occlusion using a guide sheath (GS) and a curette 4 and have now used this method in a number of patients.
In this study, we evaluated the usefulness of bronchial occlusion using a GS and curette by retrospectively reviewing all consecutive patients in whom we have performed this procedure.
MATERIALS AND METHODS

Subjects
We performed bronchial occlusion with an EWS for management of persistent air leak that was inoperable because of the patient's general condition or for control of intractable hemoptysis. The persistent air leak was defined as an air leak that lasted for > 5 days despite conventional treatment such as pleurodesis, and intractable hemoptysis was defined as expectoration of blood on > 5 occasions per day for > 2 weeks that was refractory to bronchial artery embolization. We enrolled 30 consecutive patients who underwent bronchial occlusion under mild sedation between October 2014 and February 2018.
The persistent air leak occurred on a background of emphysema in 23 cases and interstitial pneumonia in 12 (with some overlap), while intractable hemoptysis was the result of a combination of lung aspergilloma and nontuberculous mycobacterium in 2 and lung cancer in 1.
Materials
The devices used were a flexible bronchoscope (BF-1T260 or BF-1TQ290; Olympus Ltd, Tokyo, Japan) and a GS (SG-201C; Olympus Ltd) that was customized by cutting 30 mm off the proximal end to become the tip of the curette exposed outside the GS when the curette was inserted into the GS (CC-4CR-1; Olympus Ltd; Fig. 1A ). Three sizes of EWS are available, with diameters of 5 mm (small), 6 mm (medium), and 7 mm (large). A small incision was made near the nub at the broad end of the EWS using the tip of an 18-G injection needle to insert the tip of the curette (Fig. 1B ). We made a 2-0 or 3-0 nylon suture thread loop at the back end of each EWS to facilitate the removal of the EWS from the bronchus (Fig. 1C ). Caution is always necessary when manipulating products in a way they were not originally designed for; however, we have not encountered any instances of damage to the silicone spigot as a result of these maneuvers.
Intervention
Pethidine hydrochloride (35 mg) was administered subcutaneously 30 minutes before the procedure as premedication. Each patient underwent insertion of the bronchoscope through an endotracheal tube (inner diameter 8 mm; Portex; Smiths Medical Ltd, Minneapolis, MN) that were placed using the bronchoscope as a guide under local anesthesia and mild sedation with 3 to 4 mg of intravenous midazolam.
The curette and GS were inserted through the working channel of the bronchoscope with the curette tip outside the GS. We placed the curette tip into the EWS (Fig. 1D ). Next, we inserted the EWS into the target bronchus ( Fig. 1E ). After the target bronchus was occluded, the curette was pulled back through the GS while pushing the EWS with the GS (Fig. 1F ). We then pulled back the GS and A, The guide sheath is customized by cutting 30 mm off the proximal end. B, A small incision is made near the nub at the broad end of the endobronchial Watanabe spigot (EWS) and the tip of an 18-G injection needle is used to insert the tip of the curette. C, After insertion of the 18-G needle into the spigot, the suture thread is inserted via the tip of the needle and passed by pulling out the needle. D, The curette tip is placed into the EWS (the suture thread loop at the end of the EWS is for convenient removal of the EWS from the bronchus). E, The EWS is inserted into the target bronchus. F, The curette is pulled back through the guide sheath while pushing the EWS with the guide sheath. G, The guide sheath is pulled back and 1 turn of the occlusion procedure is completed.
completed 1 turn of the occlusion procedure ( Fig. 1G ).
The target bronchi were identified as follows. In patients with pneumothorax, the bronchus responsible for the air leak was identified or inferred on chest computed tomography and/or a balloon occlusion test. In patients with hemoptysis, the bleeding site was considered as the target bronchus.
The spigot used was selected from 3 sizes (small, 5 mm; medium, 6 mm; or large, 7 mm) depending on the diameter of the target bronchus measured on high-resolution computed tomography images; the small size was selected when the inner diameter of the target bronchus on the images was 3 to 4 mm, the medium size for an inner diameter of 4 to 6 mm, and the large size for an inner diameter of 6 to 7 mm. However, because the bronchus tends to expand, a one-sizelarger spigot was selected for patients in whom high-resolution computed tomography images were obtained without adequate inspiratory breathing and for those with emphysema to avoid the spigot being inserted too peripherally.
We obtained authorization to perform this study from the National Organization Himeji Medical Center Ethics Committee (registration number 27-13). Each study participant provided informed consent, allowing us to provide treatment using the procedure outlined above and to use the data obtained for research purposes.
Data Analysis
We measured the success rate of the insertion of EWS devices into the target bronchi and the procedure time for each EWS insertion (total procedure time/total number of EWS devices used). The time taken to insert 1 EWS into the target bronchus (from the insertion of the bronchoscope into the intratracheal tube to successful insertion of 1 EWS into the target bronchus) was evaluated on the video images for the most recent 10 procedures. We also investigated patient outcomes. The reduction of air leak was evaluated by observation of the number of bubbles in the underwater sealed flask in the awake state on the day following bronchial occlusion.
RESULTS
The 30 patients (29 male, 1 female) had a median age of 72 (range, 55 to 86) years. Twentyseven patients had a persistent air leak and 3 had hemoptysis. Five of the 27 patients with persistent air leak had empyema with fistula, 19 had an intractable pneumothorax, and 3 had a postoperative bronchial fistula.
The outcomes of bronchial occlusion using a GS and curette for the 30 cases are summarized in Table 1 . Bronchial occlusion was performed 1 to 3 (mean 1.5) times per patient. Bronchial occlusion with an EWS was performed in 143 target bronchi [mean 4.9 (range, 2 to 9) bronchi/ patient]. In total, 143 EWS devices for bronchial occlusion were used. The success rate of the target bronchial occlusion was 98.6% (141/143). The mean time is taken to perform the full bronchial occlusion procedure (from insertion of the intratracheal tube to extubation after the procedure, excluding balloon occlusion test time) divided by the number of EWS devices inserted was 8.1 (range, 4.5 to 15.5) minutes. For the 10 most recent cases, the median time is taken to insert 1 EWS (from insertion of the EWS into the intratracheal tube to successful insertion of the EWS into the target bronchus) was 110 (range, 40 to 521) seconds. In the 10 most recent cases, the target bronchial occlusion success rate was 100% (37/37). Dislocation and expectoration of the EWS within 4 weeks of the occlusion procedure was observed in 5 (3.6%) of 137 procedures but did not cause a relapse of pneumothorax, except in 1 patient who required reocclusion of an EWS.
The patient outcomes were as follows. Reduction in air leak was obtained in all 27 patients after bronchial occlusion using an EWS, with complete cessation of the leak in 26 patients; however, 16 of these patients received combined therapy, including pleurodesis performed after bronchial occlusion. For pleurodesis, depending on the patient's overall state of health, we used ≥ 1 of the following substances at the discretion of the attending physician: autologous blood, 50% glucose solution, minocycline, talc, and OK-432. Minocycline or a 50% glucose solution was used mainly in patients with interstitial pneumonia. The hemoptysis stopped in all 3 cases. No procedure-related complications were observed.
The EWS was removed in 12 of 30 patients [median duration of the placement, 197 d (range, 42 to 417 d)] but not in the remaining patients, who had background disease that resulted in a poor overall state of health. Postobstructive pneumonia was observed in 2 of 30 patients during placement that was not serious and improved by antimicrobial treatment.
DISCUSSION
Bronchial occlusion using an EWS is a procedure that was originally developed by Watanabe et al 1 and has been reported to be an effective treatment for intractable pneumothorax. However, plugging an EWS into a target bronchus correctly is not always straightforward. Using the conventional technique, which involves grasping forceps, the operator needs to align the direction of the EWS with the direction of the intended bronchus by making an angle pushing the EWS to the bronchial wall (the heel-kick method; Fig. 2A ). However, this method requires a great deal of skill, and the EWS may slip from the forceps and migrate (Fig. 2B) .
Several techniques have been devised to overcome the insertion difficulties encountered when performing bronchial occlusion. [2] [3] [4] [5] An occlusion method that involves bending and rotation of a curette was found to allow an easy change in direction of the tip of the EWS and easy insertion into the target bronchus 3,6 (Fig. 2C) . However, the traditional insertion technique using a curette entails pushing the EWS with a bronchoscope while pulling off the curette and embedding the EWS. This results in temporary loss of the endoscopic view and may cause the EWS to fall out of the target bronchus (Fig. 3A) . Conversely, if the EWS is pushed strongly to prevent it from falling out, it might be inserted too deeply, especially in a patient with bronchiectasis or emphysema (Fig. 3B ). Furthermore, an EWS cannot be inserted into a target bronchus that is sharply branching because it is too difficult to manipulate the tip of the bronchoscope (Fig. 3C) .
Therefore, we have devised an occlusion method using a GS and curette whereby the EWS is clearly visible during the procedure. This method enables easy insertion of the EWS, even into an upper lobe bronchus, where it is difficult to insert the tip of the bronchoscope completely.
In this study, the success rate was 98.6%, although the target bronchi included the upper bronchi in 25 of the 30 cases. Moreover, the success rate was 100% in the 10 most recent cases (in which the upper lobe bronchus was the target in 7 cases). Another benefit of using a GS and curette is that the force of the push can be transmitted through the curette to the EWS in a curved direction to some degree, which enables the EWS to be placed firmly in the target bronchus (Fig. 2D ). It is very important when performing bronchial occlusion to arrange the target bronchus, EWS, and gripping forceps coaxially to transmit the force of the push. However, this is difficult, especially when there is a sharp branching of the bronchus. An EWS may migrate if dislodged from the bronchus. Sasada et al 7 reported that the EWS migrated in 4 of 20 patients who underwent bronchial occlusion with an EWS. In our study, the rate of dislocation and expectoration of the EWS within 4 weeks was only 3.6% (5/137), which seems to be comparatively low. Kida et al 5 reported that the EWS was placed within 10 minutes using a rotatable biopsy forceps method, and Morikawa et al 6 reported that the median time per EWS occlusion was 158.5 (range, 65 to 528) seconds using the curette method. Although the patient backgrounds and operator proficiency were not the same in these studies, our median insertion time of 110 seconds per EWS (from the insertion of 1 EWS into the intratracheal tube to successful insertion of 1 EWS into the target bronchus) can be considered favorable. It is important that the cost of any such procedure be as low as possible. Given the advantages of the EWS outlined above, the cost of the GS (about 100 US dollars in Japan) is considered acceptable at least for cases with sharply branching target bronchi, such as those in an upper lobe. We think that this method has the potential to contribute to successful bronchial occlusion.
Given that there is particularly extensive collateral ventilation in emphysema, 8 which often involves multiple culprit bronchi and leads to difficulty in conclusively identifying the target bronchus for balloon occlusion, several EWSs were needed in all patients, and repeat procedures were required in 13 cases. In this study, EWS occlusion was combined with pleurodesis in 16 of 27 cases, which made it difficult to determine the short-term and long-term effects of EWS occlusion alone. However, collateral ventilation often disturbed complete cessation of air leak with EWS, and it was necessary to combine pleurodesis with EWS occlusion. However, even in the cases in which air leak was not completely stopped by EWS alone, decreases in air leak were observed.
It has been recommended that an EWS be removed in 3 to 6 months if it has served its purpose because of the risks of obstructive pneumonia and because of the difficulty removing the device when granulation occurs during long-term placement. 4 However, given that silicone is biocompatible, 9 long-term placement is acceptable if the effect of an EWS needs to be maintained or if the patient is in a poor state of health. The EWSs was permanently placed in the 3 cases of hemoptysis to maintain their effect, that is, 1 case of lung cancer and 2 cases of Mycobacteria and Aspergillus infection, which subsequently improved. Given that Mycobacteria and Aspergillus are obligate aerobes, bronchial occlusion with EWSs might be effective for these infections by restricting air ventilation and preventing dissemination to other bronchi.
In conclusion, bronchial occlusion using a GS and curette is a novel technique that enables easy insertion of an EWS within 2 minutes, even in the upper lobe bronchus, where it is difficult to insert the tip of the bronchoscope completely without loss of the endoscopic view during placement. Although the EWS is not readily available at this time in several countries, including the United States, where it has yet to secure regulatory approval, this technique is safe and extremely useful. We believe that our experience in this small case series will be clinically useful for other respiratory clinicians.
